MOSCOW (Reuters) - Testing for HIV and tuberculosis has fallen in Eastern Europe and Central Asia during the coronavirus pandemic and could lead to higher mortality rates, a U.N. special envoy for AIDS said on Wednesday.

Médecins Sans Frontières conducted a webinar on 25 November 2020 reviewing the findings of the recently released report Step Up for TB 2020: Tuberculosis Policies in 37 Countries.

TDR, in partnership with the World Health Organization Global TB Program, has developed an interactive web-based toolkit that supports national TB programs and other partners to conduct implementation research designed to evaluate digital technologies for TB care.

Scientists have developed a lung-on-chip model to study how the body responds to early tuberculosis (TB) infection, according to findings published today in eLife.

23 November 2020, KIEV, UKRAINE / THE HAGUE, NETHERLANDS: Ukraine is the first country in the world, under programmatic conditions, to provide tuberculosis (TB) patients with the groundbreaking new BPaL treatment. This three-drug treatment is meant for patients with extensively drug-resistant TB (XDR-TB) and is expected to have a higher success rate than previous treatments, doing away with painful daily injections. This deadly infectious disease currently ranks as the third cause of death in Ukraine among communicable, maternal, neonatal and nutritional diseases.

Diptendu Bhattacharya and Ashna Ashesh, both multidrug-resistant TB (MDR-TB) survivors and associated with Survivors Against TB, highlight the enormous burden of drug-resistant TB in India and how best to deal with the challenges.

USD 7.5 million to support and bolster the fight against TB by civil society, community-based, and grassroots organizations for communities, rights and gender within the TB response through Challenge Facility for Civil Society was announced during the 33rd Stop TB Partnership Board meeting, held virtually on 18-20 November 2020. This represents a historic three-fold budget increase since Round 9.

To mark World Children’s Day and World Antimicrobial Awareness Week, the World Health Organization conducted an #EndTB webinar on 20 November 2020 to discuss the impact of drug-resistant TB on children, adolescents and their families.

EGPAF, WHO, PEPFAR, UNAIDS, Stop TB Partnership and FBOs: World Children’s Day statement on advances in access to paediatric HIV and TB diagnosis and treatments

Оn the occasion of World Children's Day and World Antimicrobial Awareness Week, Dr Tereza Kasaeva, Director of the World Health Organization (WHO) Global TB Program delivered a special message highlighting the challenges of overcoming the drug-resistant TB crisis in children and adolescents.